transferrin has been researched along with Goiter, Nodular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonangeli, L; Braverman, LE; Castagna, MG; Corbo, R; de Souza, HN; Driedger, A; Düren, C; Fast, S; Graf, H; Grupe, P; Harper, W; Hegedüs, L; Huysmans, DA; Leung, AM; Magner, J; Marriott, C; Pacini, F; Pinchera, A; Proust-Lemoine, E; Purvis, A; Rachinsky, I; Reiners, C; Vaisman, M; Watt, T; Wemeau, JL | 1 |
| Andersen, PB; Bastholt, L; Boel-Jørgensen, H; Bonnema, SJ; Fast, S; Grupe, P; Hegedüs, L; Nielsen, VE | 1 |
2 trial(s) available for transferrin and Goiter, Nodular
| Article | Year |
|---|---|
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
Topics: Aged; Chemotherapy, Adjuvant; Delayed-Action Preparations; Female; Goiter, Nodular; Humans; Iodine Radioisotopes; Male; Middle Aged; Organ Size; Recombinant Proteins; Single-Blind Method; Thyroid Function Tests; Thyrotropin Alfa; Treatment Outcome | 2014 |
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Goiter, Nodular; Humans; Iodine Radioisotopes; Patient Satisfaction; Thyroid Gland; Thyrotropin Alfa; Time Factors; Treatment Failure | 2012 |